Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3521.00	1340.81	37.03
Graham Fair Price	-20.74	49.05	61.89
PEG	89.86	-0.06	0.03
Price/Book	6.50	1.81	1.70
Price/Cash Flow	76.19	35.77	20.30
Prices/Earnings	78.64	9.53	-5.33
Price/Sales	-27.56	5.01	6.91
Price/FCF	76.19	35.77	20.30
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-62.58	0.15	-0.40
ROA	-35.39	< 0.005	< 0.005
ROE	-0.08	0.05	-40.38
ROIC	-0.06	0.03	-37.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-74.46
Dividends QOQ	0.04	0.02	-39.78
EBIT QOQ	-1.68	1.56	-6.76
EPS QOQ	-1.71	1.61	-5.91
FCF QOQ	-0.11	-0.38	-247.47
Revenue QOQ	-0.41	0.51	22.05
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	823.15	533.31	-35.21
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.27	0.26	-1.95
Quick Ratio	847.87	1.34	-99.84
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	46.17	47.40	2.66
Cash	115.02	23.09	-79.93
Capex	-0.12	-0.07	39.67
Free Cash Flow	3.87	2.40	-37.95
Revenue	11.38	17.18	50.92
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	77.05	0.46	-99.40
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.48	-12.41	-737.73
Naive Interpretation	Member

06 - Financial Health · Bad

Rating